Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells
Type
Marcus Borenäs
PhD student
Dan Emil Lind
PhD student
Ruth Palmer
Professor at Department of Biochemistry and Cell Biology
I want to impart those around me with my enthusiasm for research and to train the next generation scientist.